LMNA_mScarlet-I_Donor Citations (1)
Originally described in: Marker-free co-selection for successive rounds of prime editing in human cells.Levesque S, Mayorga D, Fiset JP, Goupil C, Duringer A, Loiselle A, Bouchard E, Agudelo D, Doyon Y Nat Commun. 2022 Oct 7;13(1):5909. doi: 10.1038/s41467-022-33669-z. PubMed Journal
Articles Citing LMNA_mScarlet-I_Donor
Articles |
---|
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient. Meijer TG, Martens JWM, Prager-van der Smissen WJC, Verkaik NS, Beaufort CM, van Herk S, Robert-Finestra T, Hoogenboezem RM, Ruigrok-Ritstier K, Paul MW, Gribnau J, Bindels EMJ, Kanaar R, Jager A, van Gent DC, Hollestelle A. Cancers (Basel). 2024 Feb 10;16(4):741. doi: 10.3390/cancers16040741. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.